Arterial hypertension is a chronic disease that affects approximately 40% of the population, with higher incidence at older ages. Arterial hypertension is a risk factor for other cardiovascular diseases, such as heart failure, stroke, atherosclerosis and also chronic renal disease. It is estimated that more than 50% of deaths from coronary diseases and stroke occur in hypertensive patients; for this reason, hypertension produces high costs in health and constitutes a public health problem. In this context, the development of nonpharmacological […]